2-Pyridinecarboxamide, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methyl-
2-Pyridinecarboxamide, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methyl- Basic information
- Product Name:
- 2-Pyridinecarboxamide, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methyl-
- Synonyms:
-
- 2-Pyridinecarboxamide, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methyl-
- AZD-9574
- PPAR,Peroxisome proliferator-activated receptors,breast cancer,inhibit,AZD-9574,HRR,HRR-deficient cells,homologous recombination repair,HRD+,AZD 9574,Advanced Solid Malignancy,Inhibitor,aberrant DNA repair,AZD9574
- 6-fluoro-5-[4-[(5-fluoro-2-methyl-3-oxo-4H-quinoxalin-6-yl)methyl]-1-piperazinyl]-N-methyl-2-pyridinecarboxamide
- 6-Fluoro-5-[4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydro-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methylpyridine-2-carboxamide
- 6-Fluoro-5-(4-((5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl)piperazin-1-yl)-N-methylpicolinamide
- AZD-9574, 10 mM in DMSO
- AZD-9574 ，E2147
- CAS:
- 2756333-39-6
- MF:
- C21H22F2N6O2
- MW:
- 428.44
- Product Categories:
-
- api
- Mol File:
- 2756333-39-6.mol
2-Pyridinecarboxamide, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methyl- Chemical Properties
- Density
- 1.45±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- pka
- 8.17±0.20(Predicted)
- form
- Solid
- color
- White to yellow
- InChI
- InChI=1S/C21H22F2N6O2/c1-12-20(30)27-18-14(25-12)4-3-13(17(18)22)11-28-7-9-29(10-8-28)16-6-5-15(21(31)24-2)26-19(16)23/h3-6H,7-11H2,1-2H3,(H,24,31)(H,27,30)
- InChIKey
- WXRCLFFPZXJCLS-UHFFFAOYSA-N
- SMILES
- C1(C(NC)=O)=NC(F)=C(N2CCN(CC3C=CC4=C(C=3F)NC(=O)C(C)=N4)CC2)C=C1
2-Pyridinecarboxamide, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methyl- Usage And Synthesis
Uses
AZD-9574 is a potent and brain penetrant PARP1 inhibitor and shows >8000-fold selectivity for PARP1 compared to PARP2/3/5a/6. AZD-9574 acts by selectively inhibiting and trapping PARP1 at the sites of SSBs. AZD-9574 is an anti-cancer agent and can be used for HRD+?breast cancer and advanced solid malignancies research[1].
in vivo
AZD-9574 (3 mg/kg) shows sustained tumour growth suppression resulting in a significantly extended survival of tumour-bearing mice, in intracranial xenograft model of breast cancer brain metastases[1].
IC 50
PPAR
References
[1] Hybrid meeting divulges structures of drug candidates
[2] 1.Kunzah Jamal, et al. Abstract 2609: AZD9574 is a novel, brain penetrant PARP-1 selective inhibitor with activity in an orthotopic, intracranial xenograft model with aberrant DNA repair. Cancer Res?(2022) 82 (12_Supplement): 2609.
2-Pyridinecarboxamide, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methyl-Supplier
- Tel
- 15317229551
- 15151849396@163.com
- Tel
- 5108538618
- suger.wang@chemfuture.com
- Tel
- 021-56491756 13512199871
- 2819742715@qq.com
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 18149758185
- sales-cpd@caerulumpharma.com